Literature DB >> 16955620

[New perspectives in the primary care of the chronically ill--against the "tyranny of the urgent". Part 2: The chronic care model und case management as the basis of a forward-looking approach to primary care].

Ferdinand M Gerlach1, Martin Beyer, Kristina Saal, Monika Peitz, Jochen Gensichen.   

Abstract

Family medicine remains strongly influenced by reactive medicine ('tyranny of the urgent') and the fragmentation of healthcare associated with it. In the first part of the present article the increasing practical and economic relevance of chronic diseases and multimorbidity were analyzed as a fundamental challenge for primary care and family medicine in particular. Part two describes a forward-looking approach to guidelines and special tools which are able to guide and support future healthcare tasks of general practice. Wagner's Chronic Care Model, which was developed on the basis of numerous controlled studies, integrates empirical results, theoretical ideas and real experience within a comprehensive concept for the treatment of chronic diseases. The model focuses on the'productive interaction' between an active patient and a proactive practice team. The various elements of the model help to better understand healthcare in general practices, for example by establishing reminder and recall systems by means of a structured reorganization, through patient registers, the implementation of consultation hours for chronically ill patients as well as patient training. 'Case management' is essential to the success of structured care. Taking care of patients with major depression as an example, it is demonstrated how case management through practice assistants in general practices enables the individual needs of chronically ill patients to be better taken into account. The professionalism of the practice team with new roles and task sharing as well as the implementation of modern strategies for the care of chronically ill patients provide a new chance and a sharpened profile for general practices of the future.

Entities:  

Mesh:

Year:  2006        PMID: 16955620

Source DB:  PubMed          Journal:  Z Arztl Fortbild Qualitatssich        ISSN: 1431-7621


  6 in total

1.  Disclosure of new health problems and intervention planning using a geriatric assessment in a primary care setting.

Authors:  Christiane Annette Muller; Renate Klaassen-Mielke; Erika Penner; Ulrike Junius-Walker; Eva Hummers-Pradier; Gudrun Theile
Journal:  Croat Med J       Date:  2010-12       Impact factor: 1.351

2.  The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial.

Authors:  Anja Frei; Corinne Chmiel; Hansueli Schläpfer; Beatrice Birnbaum; Ulrike Held; Johann Steurer; Thomas Rosemann
Journal:  Cardiovasc Diabetol       Date:  2010-06-15       Impact factor: 9.951

3.  Depression risk in female patients with osteoporosis in primary care practices in Germany.

Authors:  J Drosselmeyer; M A Rapp; P Hadji; K Kostev
Journal:  Osteoporos Int       Date:  2016-03-30       Impact factor: 4.507

4.  Applicability of the Assessment of Chronic Illness Care (ACIC) instrument in Germany resulting in a new questionnaire: questionnaire of chronic illness care in primary care.

Authors:  Jost Steinhaeuser; Katja Goetz; Dominik Ose; Katharina Glassen; Iris Natanzon; Stephen Campbell; Joachim Szecsenyi; Antje Miksch
Journal:  BMC Health Serv Res       Date:  2011-07-07       Impact factor: 2.655

Review 5.  Chronic-Care-Management Programs for Multimorbid Patients with Diabetes in Europe: A Scoping Review with the Aim to Identify the Best Practice.

Authors:  Julia Heike Brettel; Ulf Manuwald; Henriette Hornstein; Joachim Kugler; Ulrike Rothe
Journal:  J Diabetes Res       Date:  2021-11-09       Impact factor: 4.011

6.  Diabetic patient assessment of chronic illness care using PACIC.

Authors:  Maria Malliarou; Christina Desikou; Eleni Lahana; Styliani Kotrotsiou; Theodosios Paralikas; Athanasios Nikolentzos; Evangelia Kotrotsiou; Pavlos Sarafis
Journal:  BMC Health Serv Res       Date:  2020-06-16       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.